Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Glenmark Pharmaceuticals Limited
Press Release Mar 20 2025
Business
Mar 21 2025
3 min read

Press Release Mar 20 2025

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 20, 2025, titled "Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2%(OTC)".

View Attachment